From: Prospective study of recovery from copperhead snake envenomation: an observational study
Characteristic | Number of subjects (n, %) |
---|---|
Enrolled subjects | 20 (100%) |
Completed 28 days of study participation | 20 (100%) |
Sex | |
Male (n, %) | 10 (50%) |
Age | |
Age (years) (median, range) | 37 (19–76) |
Aged ≥ 65 years | 3 (15%) |
Race and ethnicity | |
White race | 16 (80%) |
Black or African American race | 4 (20%) |
Hispanic or Latino ethnicity | 0 (0%) |
Study site | |
Duke University Medical Center (Durham, NC) | 12 (60%) |
East Carolina University/Vidant Medical Center (Greenville, NC) | 3 (15%) |
St. Joseph Regional Health Center (Bryan, TX) | 3 (15%) |
Scott and White Memorial Hospital (Temple, TX) | 1 (5%) |
University of Virginia (Charlottesville, VA) | 1 (5%) |
Envenomation location | |
Upper extremity | 10 (50%) |
Envenomation severity at enrollment | |
Mild | 1 (5%) |
Moderate | 16 (80%) |
Severe | 3 (15%) |
Treatment | |
Treated with antivenom | 15 (75%) |
Total antivenom dose (vials) (among patients receiving) (median, range) | 14 (4, 24) |
Duration of Hospitalization (hours) (median, range) | 35.5 (5, 49) |